Literature DB >> 9013015

Plasma endothelin-1 levels in adult patients undergoing coronary revascularization.

K St Rammos1, G J Koullias, J D Hatzibougias, N P Argyrakis, P G Panagopoulos.   

Abstract

Cardiopulmonary bypass is thought to injure all endothelial cells, mainly by cell-to-cell interaction with activated granulocytes which, augmented by endothelin-1 (ET-1), enhance the generation of superoxide radicals. These radicals on the other hand, may sustain and prolong endothelial injury. In the present study, by means of a magnetic separation radioimmunoassay procedure, ET-1 levels were measured in 10 adult patients undergoing coronary artery bypass surgery, in 10 perioperative phases, in order to reconfirm and further elucidate the effect of cardiopulmonary bypass on endothelial secretion of ET-1. ET-1 levels before cardiopulmonary bypass showed a definite rising trend, especially after median sternotomy. After induction of cardiopulmonary bypass, ET-1 levels increased significantly compared with preoperative values (P < 0.01). ET-1 levels in stable angina patients during and after aortic cross-clamping were strongly and positively correlated with preoperative mean pulmonary artery pressure (r = 0.79, n = 7, P < 0.05 and r = 0.92, n = 7, P = 0.05) respectively. After the first hour in the intensive care unit, ET-1 levels in three patients with unstable angina were considerably higher than in those with stable angina, a fact that deserves further consideration and study.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9013015     DOI: 10.1016/s0967-2109(96)00036-1

Source DB:  PubMed          Journal:  Cardiovasc Surg        ISSN: 0967-2109


  3 in total

1.  Potential role of endothelin receptor antagonists in the setting of cardiopulmonary bypass: relevance to myocardial performance.

Authors:  A Ergul; C Joffs; A C Walker; F G Spinale
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

2.  Endothelin receptor expression and pharmacology in human saphenous vein graft.

Authors:  J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

3.  Endothelin-A receptor inhibition after cardiopulmonary bypass: cytokines and receptor activation.

Authors:  Rachael L Ford; Ira M Mains; Ebony J Hilton; Scott T Reeves; Robert E Stroud; Fred A Crawford; John S Ikonomidis; Francis G Spinale
Journal:  Ann Thorac Surg       Date:  2008-11       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.